Healthcare provider profile · identity verified

John Kenneth Mcguire

Nurse Practitioner · DAMASCUS, OH · NPI 1245722156

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	327	82
Levothyroxine Sodium	Levothyroxine Sodium	250	58
Amlodipine Besylate	Amlodipine Besylate	190	54
Lisinopril	Lisinopril	183	57
Omeprazole	Omeprazole	154	45
Losartan Potassium	Losartan Potassium	152	36
Rosuvastatin Calcium	Rosuvastatin Calcium	152	42
Metoprolol Succinate	Metoprolol Succinate	146	39
Furosemide	Furosemide	132	30
Escitalopram Oxalate	Escitalopram Oxalate	131	29
Simvastatin	Simvastatin	127	22
Metformin Hcl	Metformin Hcl	119	34
Montelukast Sodium	Montelukast Sodium	107	24
Hydrochlorothiazide	Hydrochlorothiazide	105	38
Pantoprazole Sodium	Pantoprazole Sodium	103	33
Alprazolam	Alprazolam	98	21
Meloxicam	Meloxicam	93	27
Glipizide	Glipizide	83	16
Albuterol Sulfate Hfa	Albuterol Sulfate	82	25
Metformin Hcl Er	Metformin Hcl	82	23
Tizanidine Hcl	Tizanidine Hcl	80	25
Buspirone Hcl	Buspirone Hcl	77	26
Trazodone Hcl	Trazodone Hcl	76	21
Ezetimibe	Ezetimibe	74	25
Gabapentin	Gabapentin	74	20
Mirtazapine	Mirtazapine	71	17
Eliquis	Apixaban	70	13
Metoprolol Tartrate	Metoprolol Tartrate	69	20
Tamsulosin Hcl	Tamsulosin Hcl	67	15
Tramadol Hcl	Tramadol Hcl	64	18
Citalopram Hbr	Citalopram Hydrobromide	63	16
Lorazepam	Lorazepam	62	13
Potassium Chloride	Potassium Chloride	62	16
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	61	suppressed
Glipizide Er	Glipizide	59	17
Fluoxetine Hcl	Fluoxetine Hcl	56	suppressed
Carvedilol	Carvedilol	55	11
Clopidogrel	Clopidogrel Bisulfate	53	15
Famotidine	Famotidine	53	18
Fluticasone Propionate	Fluticasone Propionate	53	20
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	52	11
Sertraline Hcl	Sertraline Hcl	51	12
Pregabalin	Pregabalin	48	11
Bumetanide	Bumetanide	47	12
Ozempic	Semaglutide	45	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	43	suppressed
Alendronate Sodium	Alendronate Sodium	42	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	40	12
Prednisone	Prednisone	40	24
Amitriptyline Hcl	Amitriptyline Hcl	38	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	38	suppressed
Trulicity	Dulaglutide	36	suppressed
Clonazepam	Clonazepam	35	suppressed
Glimepiride	Glimepiride	32	suppressed
Xarelto	Rivaroxaban	32	suppressed
Donepezil Hcl	Donepezil Hcl	31	suppressed
Ibuprofen	Ibuprofen	30	14
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	30	suppressed
Naproxen	Naproxen	30	13
Januvia	Sitagliptin Phosphate	28	suppressed
Sucralfate	Sucralfate	28	suppressed
Duloxetine Hcl	Duloxetine Hcl	27	suppressed
Jardiance	Empagliflozin	27	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	27	11
Ropinirole Hcl	Ropinirole Hcl	27	suppressed
Breo Ellipta	Fluticasone/Vilanterol	26	suppressed
Clonidine	Clonidine	26	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	25	suppressed
Oxycodone Hcl	Oxycodone Hcl	25	suppressed
Topiramate	Topiramate	25	suppressed
Bupropion Xl	Bupropion Hcl	24	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	22	suppressed
Allopurinol	Allopurinol	21	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	21	suppressed
Digoxin	Digoxin	20	suppressed
Ketoconazole	Ketoconazole	20	suppressed
Movantik	Naloxegol Oxalate	20	suppressed
Myrbetriq	Mirabegron	20	suppressed
Synthroid	Levothyroxine Sodium	20	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	19	suppressed
Namzaric	Memantine Hcl/Donepezil Hcl	19	suppressed
Pravastatin Sodium	Pravastatin Sodium	19	suppressed
Propranolol Hcl	Propranolol Hcl	18	suppressed
Spironolactone	Spironolactone	18	suppressed
Celecoxib	Celecoxib	17	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	17	16
Olmesartan Medoxomil	Olmesartan Medoxomil	17	suppressed
Fenofibrate	Fenofibrate	16	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	16	suppressed
Paroxetine Hcl	Paroxetine Hcl	16	suppressed
Armour Thyroid	Thyroid,pork	15	suppressed
Diclofenac Sodium	Diclofenac Sodium	15	suppressed
Diltiazem Hcl	Diltiazem Hcl	15	suppressed
Risperidone	Risperidone	15	suppressed
Atenolol	Atenolol	14	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	14	suppressed
Minoxidil	Minoxidil	14	suppressed
Ondansetron Odt	Ondansetron	14	suppressed
Baclofen	Baclofen	13	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	13	suppressed
Enalapril Maleate	Enalapril Maleate	13	suppressed
Memantine Hcl	Memantine Hcl	13	suppressed
Metolazone	Metolazone	13	suppressed
Repatha Sureclick	Evolocumab	13	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	12	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	12	suppressed
Lithium Carbonate	Lithium Carbonate	12	suppressed
Meclizine Hcl	Meclizine Hcl	12	suppressed
Ondansetron Hcl	Ondansetron Hcl	12	suppressed
Propranolol Hcl Er	Propranolol Hcl	12	suppressed
Spiriva Handihaler	Tiotropium Bromide	12	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	12	suppressed
Viberzi	Eluxadoline	12	suppressed
Warfarin Sodium	Warfarin Sodium	12	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	11	suppressed
Copaxone	Glatiramer Acetate	11	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	11	suppressed
Diazepam	Diazepam	11	suppressed
Labetalol Hcl	Labetalol Hcl	11	suppressed
Methylprednisolone	Methylprednisolone	11	11
Nitroglycerin	Nitroglycerin	11	suppressed
Primidone	Primidone	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error